Want to see LFST full AI Analyst Report?
LFST Stock Chart & Stats
$12.28
$0.09(0.83%)
At close: 4:00 PM EDT
$12.28
$0.09(0.83%)
Day’s Range― - ―
52-Week Range$4.77 - $13.56
Previous CloseN/A
Volume1.84M
Average Volume (3M)4.75M
Market Cap
$4.49B
Enterprise Value$4.40B
Total Cash (Recent Filing)$225.94M
Total Debt (Recent Filing)$200.66M
Price to Earnings (P/E)90.2
Beta0.73
Next Earnings
Nov 05, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.13
Shares Outstanding382,154,140
10 Day Avg. Volume2,739,413
30 Day Avg. Volume4,747,702
Financial Highlights & Ratios
PEG Ratio-1.96
Price to Book (P/B)1.79
Price to Sales (P/S)1.91
P/FCF Ratio24.70
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue2.77
Enterprise Value/Gross Profit8.27
Enterprise Value/Ebitda33.39
Forecast
1Y Price Target
$14.63Price Target Upside19.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)0.17
Revenue Forecast (FY)$1.71B
Bulls Say, Bears Say
Bulls Say
Revenue And Visit GrowthStrong growth in both visits and revenue per visit indicates expanding utilization and improving monetization of the clinician network. The raised full-year outlook reinforces that management expects these operating drivers to persist beyond a single quarter and support continued scale.
Cash Generation And Low LeverageThe combination of substantial free cash flow and conservative leverage gives LifeStance financial flexibility to fund technology, clinical expansion, acquisitions, and shareholder returns. Cash conversion near net income also indicates that reported profitability is translating into usable internal funding.
Clinician Network ProductivityExpanding the clinician base while increasing visits per clinician demonstrates operating leverage in LifeStance’s care-delivery platform. Higher provider productivity can improve access, support patient growth, and strengthen the economics of the network as the company expands across markets.
Bears Say
Thin Profitability BufferAlthough LifeStance has turned profitable, its current margins remain modest relative to the scale of its revenue base. A thin earnings buffer leaves less room to absorb compensation, technology, support, or other operating-cost increases without slowing the pace of profit expansion.
Commercial Payer ConcentrationReliance on commercial payers makes reimbursement economics and patient access meaningfully dependent on a concentrated part of the insurance market. Changes in payer contracts, coverage decisions, or reimbursement dynamics could pressure revenue per visit and constrain durable margin improvement.
Specialty Rollout ExecutionSpecialty services offer attractive growth potential, but their expansion requires consistent clinical processes, training, capital, and navigation of state and payer requirements. These execution demands could delay scaling or limit the contribution of higher-acuity services to company-wide results.
Lifestance Health Group News
LFST FAQ
What was Lifestance Health Group’s price range in the past 12 months?
Lifestance Health Group lowest stock price was $4.77 and its highest was $13.56 in the past 12 months.
What is Lifestance Health Group’s market cap?
Lifestance Health Group’s market cap is $4.49B.
When is Lifestance Health Group’s upcoming earnings report date?
Lifestance Health Group’s upcoming earnings report date is Nov 05, 2026 which is in 16 days.
How were Lifestance Health Group’s earnings last quarter?
Lifestance Health Group released its earnings results on Aug 06, 2026. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.033 by $0.027.
Is Lifestance Health Group overvalued?
According to Wall Street analysts Lifestance Health Group’s price is currently Undervalued.
Does Lifestance Health Group pay dividends?
Lifestance Health Group does not currently pay dividends.
What is Lifestance Health Group’s EPS estimate?
Lifestance Health Group’s EPS estimate is 0.04.
How many shares outstanding does Lifestance Health Group have?
Lifestance Health Group has 382,154,140 shares outstanding.
What happened to Lifestance Health Group’s price movement after its last earnings report?
Lifestance Health Group reported an EPS of $0.06 in its last earnings report, beating expectations of $0.033. Following the earnings report the stock price went up 2.797%.
Which hedge fund is a major shareholder of Lifestance Health Group?
Currently, no hedge funds are holding shares in LFST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lifestance Health Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.63 (19.10% Upside)
$14.63 (19.10% Upside)
Blogger Sentiment
Neutral
LFST Sentiment 75%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 227.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $378.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 24.8%
Last 30 Days ▲ 24.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
132.93%
12-Months-Change
Fundamentals
Return on Equity
3.39%
Trailing 12-Months
Asset Growth
1.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Lifestance Health Group
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
LFST Company Deck
LFST Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial outperformance: material revenue growth (26%), sizable adjusted EBITDA and margin expansion (94% EBITDA growth; +500+ bps YoY), robust clinician additions and productivity gains, healthy cash generation and low leverage, plus raised full‑year guidance. Management is prioritizing disciplined reinvestment (tech, clinical excellence, marketing, compensation) and executing specialty rollouts and targeted tuck-in M&A while acknowledging near-term impacts to margins, free cash flow timing and potential EHR rollout disruption. Overall, the positives around growth, profitability, balance sheet strength and strategic investments materially outweigh the manageable near-term headwinds.View all LFST earnings summariesLFST Stock 12 Month Forecast
Average Price Target
$14.63
▲(19.10% Upside)
Technical Analysis
Acadia Healthcare
―
Universal Health
―
Clinigence Holdings
―
Hims & Hers Health
―
EUDA Health Holdings
―
Ownership Overview
30.14% Insiders
21.58% Mutual Funds
0.08% Other Institutional Investors
28.94% Public Companies and
Individual Investors